455 related articles for article (PubMed ID: 23353874)
1. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
Khurana S; Jain NK; Bedi PM
Life Sci; 2013 Mar; 92(6-7):383-92. PubMed ID: 23353874
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
Khurana S; Jain NK; Bedi PM
Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam.
Khurana S; Bedi PM; Jain NK
Chem Phys Lipids; 2013; 175-176():65-72. PubMed ID: 23994283
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
Khurana S; Jain NK; Bedi PM
Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
[TBL] [Abstract][Full Text] [Related]
5. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.
Bachhav YG; Patravale VB
Acta Pharm; 2010 Jun; 60(2):153-63. PubMed ID: 21134852
[TBL] [Abstract][Full Text] [Related]
6. Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.
Jiang Q; Wang J; Ma P; Liu C; Sun M; Sun Y; He Z
Drug Deliv Transl Res; 2018 Feb; 8(1):64-72. PubMed ID: 29181834
[TBL] [Abstract][Full Text] [Related]
7. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery.
El-Menshawe SF; Hussein AK
Pharm Dev Technol; 2013; 18(4):779-86. PubMed ID: 21913880
[TBL] [Abstract][Full Text] [Related]
9. Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies.
Yener G; Üner M; Gönüllü Ü; Yildirim S; Kiliç P; Aslan SS; Barla A
Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1466-73. PubMed ID: 21048338
[TBL] [Abstract][Full Text] [Related]
10. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
Jain SK; Gupta Y; Jain A; Amin S
Curr Drug Deliv; 2008 Jul; 5(3):207-14. PubMed ID: 18673264
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.
Khalil RM; Abd-Elbary A; Kassem MA; Ghorab MM; Basha M
Pharm Dev Technol; 2014 May; 19(3):304-14. PubMed ID: 23528038
[TBL] [Abstract][Full Text] [Related]
12. Positively charged polymeric nanoparticles: application in improving therapeutic efficacy of meloxicam after oral administration.
Khachane P; Date AA; Nagarsenker MS
Pharmazie; 2011 May; 66(5):334-8. PubMed ID: 21699066
[TBL] [Abstract][Full Text] [Related]
13. Transdermal delivery of fluvastatin loaded nanoemulsion gel: Preparation, characterization and in vivo anti-osteoporosis activity.
Kaur R; Ajitha M
Eur J Pharm Sci; 2019 Aug; 136():104956. PubMed ID: 31202895
[TBL] [Abstract][Full Text] [Related]
14. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
15. Effects of penetration enhancers on in vitro permeability of meloxicam gels.
Jantharaprapap R; Stagni G
Int J Pharm; 2007 Oct; 343(1-2):26-33. PubMed ID: 17531412
[TBL] [Abstract][Full Text] [Related]
16. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
Singh S; Gajra B; Rawat M; Muthu MS
Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
[TBL] [Abstract][Full Text] [Related]
17. Eudragit EPO nanoparticles: application in improving therapeutic efficacy and reducing ulcerogenicity of meloxicam on oral administration.
Khachane P; Date AA; Nagarsenker MS
J Biomed Nanotechnol; 2011 Aug; 7(4):590-7. PubMed ID: 21870464
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.
Duangjit S; Opanasopit P; Rojanarata T; Ngawhirunpat T
AAPS PharmSciTech; 2013 Mar; 14(1):133-40. PubMed ID: 23242556
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of novel ultradeformable liposomes: menthosomes, transfersomes and liposomes for enhancing skin permeation of meloxicam.
Duangjit S; Obata Y; Sano H; Onuki Y; Opanasopit P; Ngawhirunpat T; Miyoshi T; Kato S; Takayama K
Biol Pharm Bull; 2014; 37(2):239-47. PubMed ID: 24225259
[TBL] [Abstract][Full Text] [Related]
20. Utilization of spray drying technique for improvement of dissolution and anti-inflammatory effect of Meloxicam.
Shazly G; Badran M; Zoheir K; Alomrani A
Pak J Pharm Sci; 2015 Jan; 28(1):103-11. PubMed ID: 25553688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]